Recently, the Food and Drug Administration (FDA) has approved Rinvoq for some people with atopic dermatitis. Rinvoq is a Janus kinase (JAK) inhibitor. These drugs work by blocking an important pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results